COMMUNIQUÉS West-GlobeNewswire

Widmer Brothers Brewing’s Beloved White Gold Hazy Lager Returns
15/02/2024
Generations In the Making, This Hazy Golden Wheat Lager Balances the Scales With Elegance of Flavor Both Crisp and Smooth PORTLAND, Ore., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Widmer Brothers Brewing (“Widmer Brothers”) , [...]
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
15/02/2024
– Announced Positive Results from the Phase 3 ENERGIZE Study of Mitapivat in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia – – Presented Positive Results from Phase 2 Portion of the RISE UP Pivotal [...]
Hydreight Founder and CEO, Shane Madden, Joins Founding Member Board of the American IV Association
15/02/2024
VANCOUVER, British Columbia and LAS VEGAS, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“ Hydreight ” or the “Company ”) (TSXV:NURS)(OTCQB:HYDTF)(FSE:S06) a mobile clinical network and medical platform [...]
Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency
15/02/2024
Interim primary endpoint met; Statistically significant correlation of sorbitol with the CMT-FOM clinical outcome composite (p=0.05) Sustained, statistically significant reduction in sorbitol in govorestat-treated [...]
XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units
15/02/2024
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 15, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (NASDAQ: XRTX [...]
ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing
15/02/2024
LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced [...]
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
15/02/2024
REYKJAVIK, Iceland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced [...]
Alvotech Announces Expected Global Market Entry Dates for AVT04 Biosimilar to Stelara® (ustekinumab)
15/02/2024
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it has reached settlement agreements with Johnson [...]
Tricha Shivas Promoted to Chief of Staff and Strategy at Foundation for Sarcoidosis Research
15/02/2024
CHICAGO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) proudly announces the promotion of Tricha Shivas to Chief of Staff and Strategy. Ms. Shivas, who joined FSR in 2021 and has served [...]
MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®
15/02/2024
Reached enrollment goal of 305 patients living with Type 1 or Type 2 diabetes Primary endpoint analysis expected in 4Q 2024 Data dissemination and FDA submission expected in 2025 DANBURY, Conn. and WESTLAKE VILLAGE, [...]
King Faisal Specialist Hospital & Research Centre Holds Firm as Global and Regional Healthcare Leader
15/02/2024
RIYADH, Saudi Arabia, Feb. 15, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH&RC) has once again secured its position for the second consecutive year as a global leader in [...]
Notice to Convene the Annual General Meeting of Genmab A/S
15/02/2024
Company Announcement Genmab A/S to hold Annual General Meeting on Wednesday March 13, 2024 COPENHAGEN, Denmark; February 15, 2024 – Genmab A/S (Nasdaq: GMAB) summons the Annual General Meeting on Wednesday, March 13, [...]
RadNet and JVS SoCal Create ImagingWorks®, an Innovative Partnership to Launch Career Training Programs for Medical Imaging
15/02/2024
LOS ANGELES, Feb. 15, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announces the formation of a new [...]
Ipsen S.A. publishes its 2023 Consolidated Financial Statements
15/02/2024
Ipsen S.A. - 2023 Consolidated Financial Statements Attachment Ipsen - 2023 Consolidated Financial Statements
Ipsen S.A. publie ses comptes consolidés 2023
15/02/2024
Ipsen S.A. - Etats financiers consolidés 2023 Pièce jointe Ipsen - Comptes consolidés 2023
JOHNSON & JOHNSON MEDTECH LAUNCHES NEW PRESBYOPIA-CORRECTING INTRAOCULAR LENS TECNIS PURESEE IN EMEA
15/02/2024
Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision LIMERICK, IRELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Johnson & Johnson MedTech*, a global leader in eye health, [...]
Verona Pharma to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
15/02/2024
LONDON and RALEIGH, N.C., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the fourth quarter and full year [...]
Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance
15/02/2024
Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance Total revenues of €153.7 million, including product sales of €144.6 million Product sales surpassed pre-pandemic (2019) sales by 12% and 2022 [...]
Valneva publie son chiffre d’affaires et sa trésorerie pour l’exercice 2023 et fournit des indications préliminaires pour l’exercice 2024
15/02/2024
Valneva publie son chiffre d’affaires et sa trésorerie pour l’exercice 2023 et fournit des indications préliminaires pour l’exercice 2024 Chiffre d’affaires total de 153,7 millions d’euros dont 144,6 millions d’euros de [...]

Pages